Teva Pharmaceutical Industries Limited (NYSE: TEVA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Teva Pharmaceutical Industries Limited (NYSE: TEVA)
Listen to this Section


$34.61
+0.3900 ( +1.14% ) 718.3K

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Market Data


Open $34.61
Previous Close $34.22
Volume 718.3K
Market Cap $39.85B
Day Range $33.74 - $34.66
52 Week Range $14.99 - $37.35
Shares Outstanding 1.16B
Change % +1.14%
Net Change ▲ 0.3900
Insider Ownership N/A
Exchange NYSE
SectorBasic Materials
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year1982
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 1,113.00

Date Type Amount Purchased Purchaser
2025-09-09 Buy 1113.00 McAvoy David R.

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 09, 2025
4 Insider transactions 1 Jun 09, 2025
4 Insider transactions 1 Jun 09, 2025
4 Insider transactions 1 Jun 09, 2025
4 Insider transactions 1 Jun 09, 2025
4 Insider transactions 1 Jun 09, 2025
4 Insider transactions 1 Jun 09, 2025
4 Insider transactions 1 Jun 09, 2025
4 Insider transactions 1 Jun 09, 2025
4 Insider transactions 1 Jun 09, 2025

Latest News